Pharmaceutical Glass Packaging Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Vials (Small vials, Large vials), Bottles(Small bottles, Large bottles), Cartridges & Syringes, Ampoules), By Drug Type (Generic, Branded, Biologic), By Region and Competition, 2019-2029F

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

Summary

Report Description

Forecast Period

2025-2029

Market Size (2023)

USD 18.92 Billion

Market Size (2029)

USD 25.75 Billion

CAGR (2024-2029)

5.25%

Fastest Growing Segment

Bottles

Largest Market

North America


Market Overview

Global Pharmaceutical Glass Packaging Market was valued at USD 18.92 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 5.25% through 2029. The global pharmaceutical glass packaging market has been a crucial component of the pharmaceutical industry, ensuring the safety and integrity of drugs and medicines. Glass packaging has gained prominence due to its inert nature, impermeability to gases and moisture, and its ability to maintain the potency and stability of pharmaceutical products. The global pharmaceutical glass packaging market has witnessed significant growth in recent years, driven by the rising demand for safe and efficient packaging solutions in the pharmaceutical sector. The market encompasses a wide range of glass packaging products, including bottles, vials, ampoules, and syringes, each serving a specific purpose in the pharmaceutical supply chain.

The increasing global population, coupled with a growing prevalence of chronic diseases, has propelled the pharmaceutical industry. This surge in pharmaceutical manufacturing has directly impacted the demand for high-quality packaging solutions, with glass emerging as a preferred material. Governments and regulatory bodies worldwide have implemented stringent standards for pharmaceutical packaging to ensure product safety and quality. Glass packaging complies with these regulations, providing an effective barrier against contamination and maintaining the efficacy of drugs.

Key Market Drivers

Rising Pharmaceutical Industry Growth is Driving the Global Pharmaceutical Glass Packaging Market.

The pharmaceutical industry has been experiencing robust growth in recent years, driven by increasing global healthcare needs, advancements in medical research, and a growing population. This expansion has, in turn, led to a surge in demand for efficient and secure packaging solutions to ensure the safety and integrity of pharmaceutical products. As a result, the global pharmaceutical glass packaging market has witnessed substantial growth, playing a crucial role in safeguarding and preserving the potency of pharmaceutical formulations. The pharmaceutical industry's remarkable growth can be attributed to several factors. Advances in medical research and technology have led to the development of innovative drugs and therapies, addressing previously untreatable conditions. Additionally, the rising prevalence of chronic diseases, coupled with an aging population, has increased the demand for pharmaceutical products globally.

Moreover, the ongoing global efforts to combat pandemics and the increasing focus on preventive healthcare have further fueled the expansion of the pharmaceutical sector. Governments and private entities are investing significantly in research and development, driving the creation of new drugs and treatment modalities. Pharmaceutical products are highly sensitive to environmental factors such as light, moisture, and air. Maintaining the stability and efficacy of these products is paramount to ensure patient safety and compliance. Glass packaging has emerged as a preferred choice for pharmaceutical products due to its unique properties that address these concerns. Glass offers an impermeable barrier, protecting pharmaceuticals from external contaminants and maintaining their chemical stability. It is also inert, meaning it does not react with the contents, preventing any leaching of harmful substances into the drugs. Furthermore, glass is transparent, allowing for easy visual inspection of the product, and it is fully recyclable, aligning with the growing global focus on sustainable packaging solutions.

Rising Consumer Awareness is Driving the Global Pharmaceutical Glass Packaging Market

In recent years, the global pharmaceutical glass packaging market has experienced significant growth, propelled by the increasing awareness among consumers regarding the importance of safe and secure packaging for pharmaceutical products. The pharmaceutical industry is witnessing a paradigm shift towards glass packaging due to its numerous advantages, including safety, sustainability, and the ability to protect the integrity of sensitive drugs. This surge in consumer awareness is playing a pivotal role in shaping the market dynamics and fueling its expansion. Consumers today are more informed and discerning than ever before, and this trend is particularly evident in the pharmaceutical sector. There is a growing understanding among consumers about the potential risks associated with improper packaging of pharmaceutical products. Glass, being inert and non-reactive, is considered one of the safest materials for packaging medicines. It prevents contamination, ensures product stability, and protects the efficacy of the drugs throughout their shelf life.

The rise in awareness regarding the potential leaching of harmful chemicals from plastic packaging into medicines has led to a preference for glass as a packaging material. The transparency of glass also allows consumers to visually inspect the contents, ensuring both product authenticity and quality. These factors have contributed to a significant shift in consumer preferences towards pharmaceutical glass packaging. Another critical factor contributing to the surge in demand for pharmaceutical glass packaging is the growing emphasis on sustainability. As consumers become more environmentally conscious, there is an increasing aversion to single-use plastics and other non-biodegradable materials. Glass, being recyclable and eco-friendly, aligns with the global push towards sustainable practices. The pharmaceutical industry, in response to consumer demands for sustainable packaging solutions, is adopting glass as a preferred choice. The recyclability of glass not only reduces the carbon footprint but also aligns with the pharmaceutical industry's commitment to environmental responsibility.

The pharmaceutical glass packaging market is witnessing technological advancements and innovations to address the evolving needs of the industry and consumers. Manufacturers are investing in research and development to create glass packaging solutions that offer enhanced protection, longer shelf life, and improved user convenience. One notable development is the incorporation of smart packaging technologies. Smart pharmaceutical glass packaging can provide real-time information about the condition of the drugs, ensuring better adherence to storage and usage guidelines. This innovation is well-received by consumers who appreciate the additional layer of safety and reliability.


Download Free Sample Report

Key Market Challenges

Cost Pressures

One of the primary contributors to cost constraints in the pharmaceutical glass packaging market is the fluctuating prices of raw materials. The production of high-quality pharmaceutical glass requires specific materials such as silica sand, soda ash, and limestone. Any volatility in the prices of these essential components directly influences the overall production cost. Additionally, geopolitical factors, supply chain disruptions, and environmental regulations can contribute to raw material cost fluctuations, making it challenging for manufacturers to maintain stable pricing. The energy-intensive nature of glass manufacturing adds another layer of challenge to the industry. Melting and forming glass into intricate shapes demands substantial amounts of energy. As the global push for sustainable practices intensifies, pharmaceutical glass packaging manufacturers are under pressure to adopt eco-friendly production processes. However, implementing such changes often involves upfront capital investments, posing financial challenges for companies already grappling with cost constraints.

Keeping up with technological advancements is crucial for pharmaceutical glass packaging manufacturers to stay competitive and meet evolving industry standards. However, integrating new technologies into production processes requires significant investments. Companies facing cost constraints may find it difficult to allocate funds for research and development, hindering their ability to adopt innovations that enhance product quality and manufacturing efficiency. The pharmaceutical industry is heavily regulated, and adherence to stringent quality standards is non-negotiable. Meeting regulatory requirements often involves investing in sophisticated testing equipment, quality control measures, and compliance management systems. The associated costs, while necessary for ensuring product safety, can strain the financial resources of glass packaging manufacturers, especially those operating on tight budgets.

Key Market Trends 

Technological Advancements

The field of life sciences and clinical research has been witnessing a paradigm shift, driven by rapid technological advancements. One of the key contributors to this transformation is the evolution of microplate systems. These systems play a pivotal role in various applications, ranging from drug discovery and genomics to diagnostics and bioassays. The global microplate systems market is experiencing significant growth, propelled by innovative technologies that enhance efficiency, accuracy, and throughput in laboratory processes. Microplate systems have evolved from manual processes to highly automated and high-throughput systems. Automation not only accelerates the research and testing processes but also minimizes the chances of human error. The integration of robotic systems and advanced liquid handling technologies has greatly increased the speed and accuracy of experiments.

The integration of cutting-edge detection technologies, such as fluorescence, luminescence, and absorbance, has revolutionized microplate assays. These technologies provide researchers with enhanced sensitivity and specificity, allowing for the detection of even low-abundance biological molecules. This is particularly crucial in drug discovery and genomics research. Miniaturization of assays has become a key trend in microplate systems. By using smaller volumes of reagents and samples, researchers can reduce costs and improve efficiency. Multiplexing, which involves running multiple assays simultaneously, further amplifies the capabilities of microplate systems, allowing for the study of multiple parameters in a single experiment. The integration of informatics solutions with microplate systems has streamlined data management and analysis. Advanced software platforms enable researchers to collect, analyze, and interpret data more efficiently, contributing to faster decision-making processes. This integration is particularly valuable in industries like pharmaceuticals, where large-scale data processing is a common requirement.

Segmental Insights

Product Insights

Based on the category of Product, bottles emerged as the dominant segment in the global market for Pharmaceutical Glass Packaging in 2023. Glass bottles have long been favored in the pharmaceutical industry due to their superior barrier properties. Glass is impermeable, ensuring that pharmaceutical products are protected from external elements, such as moisture, gases, and contaminants. This is crucial for maintaining the stability and efficacy of drugs, particularly those sensitive to environmental factors. Unlike some plastic alternatives, glass is chemically inert and does not react with the contents of the bottle. This property is essential for pharmaceutical products, as any interaction between the packaging material and the drug could compromise its quality. Glass bottles provide a secure and stable environment for a wide range of medications.

The pharmaceutical industry operates under strict regulatory frameworks globally. Glass is a well-established material that meets these stringent standards. It is inert, non-toxic, and does not leach harmful substances into the pharmaceutical formulations. As regulatory scrutiny intensifies, pharmaceutical companies are opting for glass bottles to ensure compliance and gain the trust of regulatory authorities. Glass bottles offer versatile design options, allowing for various shapes and sizes to accommodate different pharmaceutical products. This flexibility in design is particularly important for medications that require specific packaging configurations, such as injectables, oral liquids, and parenteral drugs. The adaptability of glass makes it a preferred choice for pharmaceutical companies seeking customizable solutions. With an increasing focus on sustainable practices, pharmaceutical companies are turning to eco-friendly packaging solutions. Glass bottles are fully recyclable and have a minimal environmental impact compared to certain plastic alternatives. The pharmaceutical industry's commitment to reducing its carbon footprint has further propelled the adoption of glass packaging. Recent advancements in glass manufacturing technologies have enhanced the quality and efficiency of glass bottles for pharmaceutical use. Precision in molding, improved surface treatments, and innovations in glass composition contribute to the production of high-quality, reliable, and visually appealing packaging solutions. Glass offers unparalleled stability over time, ensuring the extended shelf life of pharmaceutical products. The material's resistance to degradation and permeation makes it ideal for drugs that require extended storage durations.

Drug Type Insights

The Generic segment is projected to experience rapid growth during the forecast period. Generic drugs, also known as off-patent drugs, are bioequivalent versions of brand-name pharmaceuticals. They contain the same active ingredients, have the same strength and dosage form, and are administered in the same way. The key difference lies in the absence of patent protection for generic drugs, allowing multiple manufacturers to produce and market them. This competition typically leads to lower prices, making healthcare more affordable and accessible to a broader population. The rise of generic drugs has reshaped the pharmaceutical landscape, impacting not only drug manufacturing but also the packaging industry. Pharmaceutical glass packaging, known for its superior qualities in preserving drug integrity, has become the material of choice for packaging generic medications. The glass offers a barrier against moisture, gases, and external contaminants, ensuring the stability and efficacy of the drugs over an extended period.


Download Free Sample Report

Regional Insights

North America emerged as the dominant player in the global Pharmaceutical Glass Packaging market in 2023, holding the largest market share in terms of value. North American companies have been at the forefront of technological advancements in the pharmaceutical packaging industry. Cutting-edge technologies, such as advanced glass formulations and coating techniques, have enabled manufacturers to produce glass packaging that meets the stringent requirements of the pharmaceutical sector. These innovations ensure the integrity, safety, and stability of pharmaceutical products during storage and transportation. The pharmaceutical industry is subject to rigorous regulatory standards to ensure the safety and efficacy of drugs. North America, particularly the United States and Canada, has established stringent regulatory frameworks governing pharmaceutical packaging. The compliance with these standards has become a key differentiator for North American glass packaging manufacturers, giving them a competitive edge in the global market.

Recent Developments

  • In January 2024, SGD Pharma revealed the inauguration of a fresh siliconisation facility at its advanced Saint-Quentin Lamotte (SQLM) plant. This move adds to the array of services offered in-house, consolidating the company's glass siliconisation provision. This initiative aims to bolster responsiveness, guarantee a secure supply chain, and enhance the adaptability of vial sizes.

Key Market Players

  • Corning Incorporated
  • Heartsine Technologies, Inc.
  • Nipro Corporation
  • SGD S.A.
  • Stoelzle Oberglas GmbH
  • Bormioli Pharma S.p.A.
  • West Pharmaceutical Services, Inc.
  • Schott AG
  • Gerresheimer AG
  • Shandong Pharmaceutical Glass Co., Ltd.
  • Beatson Clark
  • Ardagh Group S.A
  • Arab Pharmaceutical Glass Co.
  • Piramal Enterprises Ltd.
  • Şişecam Group
  • Owens-Illinois, Inc.

By Product

By Drug Type

By Region
  • Vials
  • Bottles
  • Cartridges & Syringes
  • Ampoules
  • Generic
  • Branded
  • Biologic
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

 

Report Scope:

In this report, the Global Pharmaceutical Glass Packaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Pharmaceutical Glass Packaging Market, By Product:

o   Vials

o   Bottles

o   Cartridges & Syringes

o   Ampoules

  • Pharmaceutical Glass Packaging Market, By Drug Type:

o   Generic

o   Branded

o   Biologic

  • Pharmaceutical Glass Packaging Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia-Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Pharmaceutical Glass Packaging Market.

Available Customizations:

Global Pharmaceutical Glass Packaging market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Pharmaceutical Glass Packaging Market has an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.    Markets Covered

1.2.2.    Years Considered for Study

1.2.3.    Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Global Pharmaceutical Glass Packaging  Market Outlook

4.1.  Market Size & Forecast

4.1.1.    By Value

4.2.  Market Share & Forecast

4.2.1.    By Product (Vials (Small vials, Large vials), Bottles(Small bottles, Large bottles), Cartridges & Syringes, Ampoules)

4.2.2.    By Drug Type (Generic, Branded, Biologic)

4.2.3.    By Region

4.2.4.    By Company (2023)

4.3.  Market Map

4.3.1.    By Product

4.3.2.    By Drug Type

4.3.3.    By Region

5.    Asia Pacific Pharmaceutical Glass Packaging  Market Outlook

5.1.  Market Size & Forecast

5.1.1.    By Value

5.2.  Market Share & Forecast

5.2.1.    By Product

5.2.2.    By Drug Type

5.2.3.    By Country

5.3.  Asia Pacific: Country Analysis

5.3.1.    China Pharmaceutical Glass Packaging  Market Outlook

5.3.1.1.        Market Size & Forecast

5.3.1.1.1.           By Value

5.3.1.2.        Market Share & Forecast

5.3.1.2.1.           By Product

5.3.1.2.2.           By Drug Type

5.3.2.    India Pharmaceutical Glass Packaging  Market Outlook

5.3.2.1.        Market Size & Forecast

5.3.2.1.1.           By Value

5.3.2.2.        Market Share & Forecast

5.3.2.2.1.           By Product

5.3.2.2.2.           By Drug Type

5.3.3.    Australia Pharmaceutical Glass Packaging  Market Outlook

5.3.3.1.        Market Size & Forecast

5.3.3.1.1.           By Value

5.3.3.2.        Market Share & Forecast

5.3.3.2.1.           By Product

5.3.3.2.2.           By Drug Type

5.3.4.    Japan Pharmaceutical Glass Packaging  Market Outlook

5.3.4.1.        Market Size & Forecast

5.3.4.1.1.           By Value

5.3.4.2.        Market Share & Forecast

5.3.4.2.1.           By Product

5.3.4.2.2.           By Drug Type

5.3.5.    South Korea Pharmaceutical Glass Packaging  Market Outlook

5.3.5.1.        Market Size & Forecast

5.3.5.1.1.           By Value

5.3.5.2.        Market Share & Forecast

5.3.5.2.1.           By Product

5.3.5.2.2.           By Drug Type

6.    Europe Pharmaceutical Glass Packaging  Market Outlook

6.1.  Market Size & Forecast

6.1.1.    By Value

6.2.  Market Share & Forecast

6.2.1.    By Product

6.2.2.    By Drug Type

6.2.3.    By Country

6.3.  Europe: Country Analysis

6.3.1.    France Pharmaceutical Glass Packaging  Market Outlook

6.3.1.1.        Market Size & Forecast

6.3.1.1.1.           By Value

6.3.1.2.        Market Share & Forecast

6.3.1.2.1.           By Product

6.3.1.2.2.           By Drug Type

6.3.2.    Germany Pharmaceutical Glass Packaging  Market Outlook

6.3.2.1.        Market Size & Forecast

6.3.2.1.1.           By Value

6.3.2.2.        Market Share & Forecast

6.3.2.2.1.           By Product

6.3.2.2.2.           By Drug Type

6.3.3.    Spain Pharmaceutical Glass Packaging  Market Outlook

6.3.3.1.        Market Size & Forecast

6.3.3.1.1.           By Value

6.3.3.2.        Market Share & Forecast

6.3.3.2.1.           By Product

6.3.3.2.2.           By Drug Type

6.3.4.    Italy Pharmaceutical Glass Packaging  Market Outlook

6.3.4.1.        Market Size & Forecast

6.3.4.1.1.           By Value

6.3.4.2.        Market Share & Forecast

6.3.4.2.1.           By Product

6.3.4.2.2.           By Drug Type

6.3.5.    United Kingdom Pharmaceutical Glass Packaging  Market Outlook

6.3.5.1.        Market Size & Forecast

6.3.5.1.1.           By Value

6.3.5.2.        Market Share & Forecast

6.3.5.2.1.           By Product

6.3.5.2.2.           By Drug Type

7.    North America Pharmaceutical Glass Packaging  Market Outlook

7.1.  Market Size & Forecast

7.1.1.    By Value

7.2.  Market Share & Forecast

7.2.1.    By Product

7.2.2.    By Drug Type

7.2.3.    By Country

7.3.  North America: Country Analysis

7.3.1.    United States Pharmaceutical Glass Packaging  Market Outlook

7.3.1.1.        Market Size & Forecast

7.3.1.1.1.           By Value

7.3.1.2.        Market Share & Forecast

7.3.1.2.1.           By Product

7.3.1.2.2.           By Drug Type

7.3.2.    Mexico Pharmaceutical Glass Packaging  Market Outlook

7.3.2.1.        Market Size & Forecast

7.3.2.1.1.           By Value

7.3.2.2.        Market Share & Forecast

7.3.2.2.1.           By Product

7.3.2.2.2.           By Drug Type

7.3.3.    Canada Pharmaceutical Glass Packaging  Market Outlook

7.3.3.1.        Market Size & Forecast

7.3.3.1.1.           By Value

7.3.3.2.        Market Share & Forecast

7.3.3.2.1.           By Product

7.3.3.2.2.           By Drug Type

8.    South America Pharmaceutical Glass Packaging  Market Outlook

8.1.  Market Size & Forecast

8.1.1.    By Value

8.2.  Market Share & Forecast

8.2.1.    By Product

8.2.2.    By Drug Type

8.2.3.    By Country

8.3.  South America: Country Analysis

8.3.1.    Brazil Pharmaceutical Glass Packaging  Market Outlook

8.3.1.1.        Market Size & Forecast

8.3.1.1.1.           By Value

8.3.1.2.        Market Share & Forecast

8.3.1.2.1.           By Product

8.3.1.2.2.           By Drug Type

8.3.2.    Argentina Pharmaceutical Glass Packaging  Market Outlook

8.3.2.1.        Market Size & Forecast

8.3.2.1.1.           By Value

8.3.2.2.        Market Share & Forecast

8.3.2.2.1.           By Product

8.3.2.2.2.           By Drug Type

8.3.3.    Colombia Pharmaceutical Glass Packaging  Market Outlook

8.3.3.1.        Market Size & Forecast

8.3.3.1.1.           By Value

8.3.3.2.        Market Share & Forecast

8.3.3.2.1.           By Product

8.3.3.2.2.           By Drug Type

9.    Middle East and Africa Pharmaceutical Glass Packaging  Market Outlook

9.1.  Market Size & Forecast

9.1.1.    By Value

9.2.  Market Share & Forecast

9.2.1.    By Product

9.2.2.    By Drug Type

9.2.3.    By Country

9.3.  MEA: Country Analysis

9.3.1.    South Africa Pharmaceutical Glass Packaging  Market Outlook

9.3.1.1.        Market Size & Forecast

9.3.1.1.1.           By Value

9.3.1.2.        Market Share & Forecast

9.3.1.2.1.           By Product

9.3.1.2.2.           By Drug Type

9.3.2.    Saudi Arabia Pharmaceutical Glass Packaging  Market Outlook

9.3.2.1.        Market Size & Forecast

9.3.2.1.1.           By Value

9.3.2.2.        Market Share & Forecast

9.3.2.2.1.           By Product

9.3.2.2.2.           By Drug Type

9.3.3.    UAE Pharmaceutical Glass Packaging  Market Outlook

9.3.3.1.        Market Size & Forecast

9.3.3.1.1.           By Value

9.3.3.2.        Market Share & Forecast

9.3.3.2.1.           By Product

9.3.3.2.2.           By Drug Type

10. Market Dynamics

10.1.   Drivers

10.2.   Challenges

11. Market Trends & Developments

11.1.   Recent Developments

11.2.   Product Launches

11.3.   Mergers & Acquisitions

12. Global Pharmaceutical Glass Packaging  Market: SWOT Analysis

13. Porter’s Five Forces Analysis

13.1.   Competition in the Industry

13.2.   Potential of New Entrants

13.3.   Power of Suppliers

13.4.   Power of Customers

13.5.   Threat of Substitute Product 

14. Competitive Landscape

14.1.   Corning Incorporated

14.1.1.    Company Snapshot

14.1.2.    Product & Services

14.1.4.    Financials (In case of listed)

14.1.5.    Recent Developments

14.1.6.    SWOT Analysis

14.2.   Heartsine Technologies, Inc.

14.3.   Nipro Corporation

14.4.   SGD S.A.

14.5.   Stoelzle Oberglas GmbH

14.6.   Bormioli Pharma S.p.A.

14.7.   West Pharmaceutical Services, Inc.

14.8.   Schott AG

14.9.   Gerresheimer AG

14.10.Shandong Pharmaceutical Glass Co., Ltd.

14.11.Beatson Clark

14.12.Ardagh Group S.A

14.13.Arab Pharmaceutical Glass Co.

14.14.Piramal Enterprises Ltd.

14.15.Şişecam Group

14.16.Owens-Illinois, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer

Figures and Tables

Frequently asked questions

down-arrow

The market size of the Global Pharmaceutical Glass Packaging Market was estimated to be USD 18.92 Billion in 2023.

down-arrow

The Global Pharmaceutical Glass Packaging Market was analyzed for the historical period of 2019 to 2022. While the base year was 2023, estimation for the year 2024 was calculated and the market growth was further forecast for 2025 to 2029.

down-arrow

Corning Incorporated, Heartsine Technologies, Inc., Nipro Corporation, SGD S.A., Stoelzle Oberglas GmbH, Bormioli Pharma S.p.A., West Pharmaceutical Services, Inc., Schott AG, Gerresheimer AG, Shandong Pharmaceutical Glass Co., Ltd., Beatson Clark, Ardagh Group S.A, Arab Pharmaceutical Glass Co., Piramal Enterprises Ltd., Şişecam Group, Owens-Illinois, Inc. were the top players operating in the Global Pharmaceutical Glass Packaging Market in 2023.

down-arrow

Rising pharmaceutical industry growth and rising consumer awareness are the major drivers for the Global Pharmaceutical Glass Packaging Market.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Pharmaceutical Glass Packaging Market to Grow with a CAGR of 5.25% through 2029

Apr, 2024

Rising pharmaceutical industry growth and rising consumer awareness are factors driving the Global Pharmaceutical Glass Packaging Market in the forecast period 2025-2029

Why Choose Us